Species: Alistipes shahii (HMT-0966) Primary Body Site: Gut
Download Options
Hide Legend
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Body Site Legend:
| SUBP-- Subgingival Plaque |
| SUPP -- Supragingival Plaque |
| PERIO -- Periodontal |
| AKE -- Attached Keratinized Gingiva |
| BMU -- Buccal Mucosa |
| HPA -- Hard Palate |
| SAL -- Saliva |
| THR -- Throat |
| PTO -- Palatine Tonsils |
| TDO -- Tongue Dorsum |
| ANA -- Anterior Nares |
| LRC -- L_Retroauricular Crease |
| RRC -- R_Retroauricular Crease |
| LAF -- L_Antecubital Fossa |
| RAF -- R_Antecubital Fossa |
| VIN -- Vaginal Introitus |
| MVA -- Mid Vagina |
| PFO -- Posterior Fornix |
| STO -- Stool |
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Human Microbiome Project Mapping (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0.01 | 0.01 | 0.15 | 0 | 0.01 | 0.04 | 0 | 0.06 | 0.10 | 2.77 |
| n | 24 | 395 | 24 | 15 | 323 | 1 | 8 | 7 | 22 | 423 | 65 | 23 | 30 | 1 | 4 | 8 | 94 | 375 |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0.28 |
| 90thp | 0.01 | 0 | 0 | 0 | 0.01 | 0 | 0.01 | 0 | 0.01 | 0 | 0.11 | 0.01 | 0.01 | 0.04 | 0 | 0.15 | 0.02 | 5.87 |
| Stdev | 0 | 0.01 | 0 | 0.01 | 0.04 | 0 | 0 | 0 | 0.02 | 0.14 | 0.63 | 0.01 | 0.02 | 0 | 0 | 0.17 | 0.62 | 3.49 |
| Prev(%) | 0 | 0.25 | 0 | 0 | 0.62 | 0 | 0 | 0 | 0 | 0.47 | 4.62 | 0 | 3.33 | 0 | 0 | 0 | 2.13 | 77.07 |
Eren V1-V3 www.pnas.org
(Data from healthy subjects.)
No Notes
Eren V3-V5 www.pnas.org
(Data from healthy subjects.)
No Notes
Human Microbiome Project 16S RefSeq (V1-V3) (Data from healthy subjects. - not published)
No Notes
Human Microbiome Project 16S RefSeq (V3-V5) (Data from healthy subjects. - not published)
No Notes
Dewhirst 35x9 (35 Taxa by 9 Oral Sites. - not published)
No Notes
Human Microbiome Project Metaphlan (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0 | 0 | 0 | 0.06 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0.03 | 0.04 | 1.21 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.09 |
| Stdev | 0 | 0 | 0 | 0.24 | 0.04 | 0 | 0 | 0 | 0.06 | 0.08 | 0.26 | 0 | 0.02 | 0 | 0 | 0.09 | 0.30 | 1.99 |
| Prev(%) | 0 | 1.26 | 0 | 5.88 | 2.13 | 0 | 0 | 0 | 12.00 | 0.70 | 3.60 | 0 | 3.13 | 0 | 0 | 7.14 | 2.02 | 68.91 |
